The Evening Versus Morning Polypill Utilization Study

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Cardiovascular DiseaseCerebrovascular DiseasePeripheral Arterial Disease
Interventions
DRUG

Cardiovascular Agents

Acetylsalicylic acid 75mg, simvastatin 40mg, lisinopril 10mg, hydrochlorthiazide 12.5mg in individual agents or a combination pill

Trial Locations (1)

3508 GA

UMC Utrecht, Utrecht

All Listed Sponsors
lead

UMC Utrecht

OTHER

NCT01506505 - The Evening Versus Morning Polypill Utilization Study | Biotech Hunter | Biotech Hunter